Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome

Dorien J. A. Lobbezoo, Roel J. W. van Kampen, Adri C. Voogd, M. Wouter Dercksen, Franchette van den Berkmortel, Tineke J. Smilde, Agnes J. van de Wouw, Frank P. J. Peters, Johanna M. G. H. van Riel, Natascha A. J. B. Peters, Maaike de Boer, George F. Borm, Vivianne C. G. Tjan-Heijnen*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

143 Citations (Web of Science)
Original languageEnglish
Pages (from-to)507-514
JournalBreast Cancer Research and Treatment
Issue number3
Publication statusPublished - Oct 2013


  • Breast cancer
  • Distant metastases
  • Subtypes
  • Prognosis
  • Survival

Cite this